• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲真菌病及其治疗对患者报告的生活质量结局的影响:系统评价。

Effect of onychomycosis and treatment on patient-reported quality-of-life outcomes: A systematic review.

机构信息

Weill Cornell Medical College, New York, New York.

Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.

出版信息

J Am Acad Dermatol. 2021 Nov;85(5):1227-1239. doi: 10.1016/j.jaad.2020.05.143. Epub 2020 Jun 2.

DOI:10.1016/j.jaad.2020.05.143
PMID:32502586
Abstract

BACKGROUND

Onychomycosis is the most common nail disorder, often causing physical, emotional, and aesthetic consequences. The effect of both the condition itself and treatment on quality of life has not been well studied.

OBJECTIVE

The objectives of this study were to systematically review the available literature describing the effect of onychomycosis and treatment on quality of life.

METHODS

We performed a search of the onychomycosis literature published before April 13, 2020. Articles were included in the review if primary data were presented, patient-reported outcome measures were used, and onychomycosis was specifically examined.

RESULTS

Thirty studies were included in the final analysis. Poorest quality-of-life scores were associated with women and fingernail involvement. Quality-of-life scores improved from baseline with all treatment types; there were greater improvements reported with oral treatments compared with topical ones.

CONCLUSIONS

This review affirms that onychomycosis significantly influences quality of life, warranting effective treatment. All treatments resulted in quality-of-life improvements; however, studies on oral and topical therapies were of higher quality than those evaluating devices. Increased efforts are needed to understand the effect of the disease and therapy as assessed by validated, nail-specific outcome measures that accurately assess patients' cosmetic, physical, and social difficulties.

摘要

背景

甲真菌病是最常见的指甲疾病,常导致身体、情感和美学方面的后果。该疾病本身及其治疗对生活质量的影响尚未得到充分研究。

目的

本研究旨在系统综述描述甲真菌病和治疗对生活质量影响的现有文献。

方法

我们对截至 2020 年 4 月 13 日发表的甲真菌病文献进行了检索。如果有主要数据、使用患者报告的结局测量、专门检查甲真菌病,则将文章纳入综述。

结果

最终分析纳入了 30 项研究。女性和指甲受累与最差的生活质量评分相关。所有治疗类型均从基线开始改善生活质量评分;与局部治疗相比,口服治疗报告的改善更大。

结论

本综述证实甲真菌病显著影响生活质量,需要有效的治疗。所有治疗均改善生活质量评分;然而,口服和局部治疗的研究质量高于评估器械的研究。需要进一步努力,使用经过验证的、专门针对指甲的结局测量来理解疾病和治疗的影响,这些测量能够准确评估患者的美容、身体和社交困难。

相似文献

1
Effect of onychomycosis and treatment on patient-reported quality-of-life outcomes: A systematic review.甲真菌病及其治疗对患者报告的生活质量结局的影响:系统评价。
J Am Acad Dermatol. 2021 Nov;85(5):1227-1239. doi: 10.1016/j.jaad.2020.05.143. Epub 2020 Jun 2.
2
The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment.艾氟康唑对角蛋白的低亲和力有助于其在局部甲真菌病治疗中的指甲穿透性和杀菌活性。
Antimicrob Agents Chemother. 2014 Jul;58(7):3837-42. doi: 10.1128/AAC.00111-14. Epub 2014 Apr 21.
3
Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.8%环吡酮甲涂剂溶液与美国用于治疗皮肤癣菌性足趾甲真菌病的新型口服抗真菌药物的药物经济学分析。
J Am Acad Dermatol. 2000 Oct;43(4 Suppl):S81-95. doi: 10.1067/mjd.2000.109069.
4
Therapies for onychomycosis a systematic review and network meta-analysis of mycological cure.甲癣的治疗:真菌学治愈的系统评价和网状Meta分析
J Am Podiatr Med Assoc. 2015 Jul;105(4):357-66. doi: 10.7547/13-110.1. Epub 2014 Jul 17.
5
An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis.一项开放性随机对照研究,旨在测试口服特比萘芬脉冲疗法单药治疗以及联合8%环吡酮胺外用制剂或5%盐酸阿莫罗芬外用制剂治疗甲真菌病的疗效和安全性。
Indian J Dermatol Venereol Leprol. 2007 Nov-Dec;73(6):393-6. doi: 10.4103/0378-6323.37056.
6
Onychomycosis: Rapid Evidence Review.甲真菌病:快速证据综述。
Am Fam Physician. 2021 Oct 1;104(4):359-367.
7
A randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis.5%阿莫罗芬溶液甲涂剂联合伊曲康唑冲击疗法与单用伊曲康唑治疗念珠菌性手指甲癣的随机试验。
Br J Dermatol. 2003 Jul;149(1):151-6. doi: 10.1046/j.1365-2133.2003.05381.x.
8
Antifungal therapy for onychomycosis in children.儿童甲癣的抗真菌治疗
Clin Dermatol. 2015 May-Jun;33(3):333-9. doi: 10.1016/j.clindermatol.2014.12.010. Epub 2014 Dec 8.
9
Efinaconazole: a new topical treatment for onychomycosis.艾氟康唑:一种治疗甲癣的新型局部用药
Skin Therapy Lett. 2014 Jan-Feb;19(1):1-4.
10
[Therapy of onychomycosis].[甲癣的治疗]
Med Klin (Munich). 2000 Nov 15;95(11):618-28. doi: 10.1007/pl00002074.

引用本文的文献

1
Experimental research on fungal inhibition using dissolving microneedles of terbinafine hydrochloride nanoemulsion for beta-1,3-glucanase.盐酸特比萘芬纳米乳溶蚀性微针抑制β-1,3-葡聚糖酶的实验研究
Nanoscale Adv. 2025 Jun 6. doi: 10.1039/d5na00163c.
2
A Double-Blind Randomised Clinical Trial of Terbinafine-Nanostructured Lipid Carriers: Should We Anticipate This Strategy for Effective Topical Treatment of Onychomycosis?特比萘芬纳米结构脂质载体的双盲随机临床试验:我们是否应期待这种策略用于甲真菌病的有效局部治疗?
Mycoses. 2025 Jun;68(6):e70076. doi: 10.1111/myc.70076.
3
Analysis of Causative Factors and Potential Predictors of Onychomycosis: A Retrospective Single-Center Study in Poland.
甲癣的致病因素及潜在预测因素分析:波兰一项回顾性单中心研究
J Fungi (Basel). 2025 Feb 9;11(2):131. doi: 10.3390/jof11020131.
4
Terbinafine in acrylic polymer for the treatment of onychomycosis in hemodialysis patients: a phase II clinical trial.用于治疗血液透析患者甲癣的丙烯酸聚合物特比萘芬:一项II期临床试验。
Front Med (Lausanne). 2024 Nov 26;11:1417985. doi: 10.3389/fmed.2024.1417985. eCollection 2024.
5
Extended Use of Topical Efinaconazole Remains Safe and Can Provide Continuing Benefits for Dermatophyte Toenail Onychomycosis.外用艾氟康唑的长期使用仍然安全,并且可为皮肤癣菌性 toenail 甲真菌病提供持续益处。 (注:这里“toenail”直译为“脚趾甲”,结合语境可能是想表达“趾甲”,整体译文稍显奇怪,推测原文可能存在部分错误表述,但按要求准确翻译如上。)
J Fungi (Basel). 2024 Aug 30;10(9):620. doi: 10.3390/jof10090620.
6
Retrospective Analysis of Onychomycosis Risk Factors Using the 2003-2014 National Inpatient Sample.利用2003 - 2014年全国住院患者样本对甲癣危险因素进行回顾性分析。
Dermatol Pract Concept. 2024 Apr 1;14(2):e2024074. doi: 10.5826/dpc.1402a74.
7
Nails in older adults.老年人的指甲问题。
Ann Med. 2024 Dec;56(1):2336989. doi: 10.1080/07853890.2024.2336989. Epub 2024 May 13.
8
Development and Validation of a Patient-Reported Outcome Measure for Fingernail and Toenail Conditions: The NAIL-Q.一种用于指甲疾病的患者报告结局量表的开发与验证:NAIL-Q量表
Clin Cosmet Investig Dermatol. 2023 Oct 27;16:3091-3105. doi: 10.2147/CCID.S429120. eCollection 2023.
9
On the Basis of Sex: Impact and Treatment of Toenail Onychomycosis in Female Patients.基于性别:女性患者趾甲甲真菌病的影响与治疗
J Clin Aesthet Dermatol. 2023 Oct;16(10):52-57.
10
A Bibliometric Analysis of the Top 100 Highly Cited Onychomycosis Publications Using SCOPUS Database (1972-2022).使用Scopus数据库(1972 - 2022年)对100篇高被引甲真菌病出版物进行的文献计量分析。
Skin Appendage Disord. 2023 Oct;9(5):333-341. doi: 10.1159/000531184. Epub 2023 Jul 12.